{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T07:48:42Z","timestamp":1676188122407},"reference-count":10,"publisher":"Academy of Medicine, Singapore","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Acad Med Singap"],"published-print":{"date-parts":[[2021,3,31]]},"DOI":"10.47102\/annals-acadmedsg.2020405","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T13:26:39Z","timestamp":1618838799000},"page":"258-260","source":"Crossref","is-referenced-by-count":2,"title":["Carbamazepine-induced toxic epidermal necrolysis in a patient despite testing\nnegative for HLA B*15:02 allele"],"prefix":"10.47102","volume":"50","author":[{"given":"Bochao","family":"Jiang","sequence":"first","affiliation":[{"name":"Singapore General Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choon Chiat","family":"Oh","sequence":"additional","affiliation":[{"name":"Singapore General Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Wei","family":"Tan","sequence":"additional","affiliation":[{"name":"Changi General Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haur Yueh","family":"Lee","sequence":"additional","affiliation":[{"name":"Changi General Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"26165","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"ref0","unstructured":"Health Sciences Authority, Singapore. Recommendations for HLA-B*1502 genotype testing prior to initiation of carbamazepine in new patients, 29 August 2013. Available at: https:\/\/www.hsa.gov. sg\/announcements\/safety-alert\/recommendations-for-hla-b-1502- genotype-testing-prior-to-initiation-of-carbamazepine-in-new-patients. Accessed on 12 October 2020."},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004;428:486.","DOI":"10.1038\/428486a"},{"key":"ref2","unstructured":"Health Sciences Authority, Singapore. HLA-B*1502 genotype testing: Towards safer use of carbamazepine, 31 December 2013. Available at: https:\/\/www.hsa.gov.sg\/announcements\/safety-alert\/ hla-b-1502-genotype-testing-towards-safer-use-of-carbamazepine. Accessed on 12 October 2020."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Sung C, Tan L, Limenta M, et al. Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of HLA-B*15:02 Genotyping as Standard-of-Care. Front Pharmacol 2020;11:527.","DOI":"10.3389\/fphar.2020.00527"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Ferrell PB Jr, McLeod HL. Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics 2008;9:1543-6.","DOI":"10.2217\/14622416.9.10.1543"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Hsiao YH, Hui RC, Wu T, et al. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations. J Dermatol Sci 2014;73:101-9.","DOI":"10.1016\/j.jdermsci.2013.10.003"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 2013;169:1071-80.","DOI":"10.1111\/bjd.12501"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Fan WL, Shiao MS, Hui RC, et al. HLA Association with Drug- Induced Adverse Reactions. J Immunol Res 2017;2017:3186328.","DOI":"10.1155\/2017\/3186328"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Pavlos R, Mallal S, Ostrov D, et al. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy. J Allergy Clin Immunol Pract 2014; 2:21-33.","DOI":"10.1016\/j.jaip.2013.11.005"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Phillips EJ, Sukasem C, Whirl-Carrillo M, et al. Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update. Clin Pharmacol Ther 2018;103:574-81.","DOI":"10.1002\/cpt.1004"}],"container-title":["Annals of the Academy of Medicine, Singapore"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T01:12:05Z","timestamp":1618881125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.annals.edu.sg\/pdf\/50VolNo3Mar2021\/V50N3p258.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":10,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.47102\/annals-acadmedsg.2020405","relation":{},"ISSN":["0304-4602"],"issn-type":[{"value":"0304-4602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,31]]}}}